Paradice Investment Management Lowered Cra Intl (CRAI) Stake By $9.80 Million, 3 Analysts Covering Medley Capital (MCC)

June 20, 2017 - By Winifred Garcia

Among 6 analysts covering Medley Capital Corp (NYSE:MCC), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. Medley Capital Corp had 10 analyst reports since August 12, 2015 according to SRatingsIntel. Wood maintained the shares of MCC in report on Friday, August 14 with “Hold” rating. The firm has “Neutral” rating by UBS given on Wednesday, October 14. As per Thursday, August 13, the company rating was downgraded by Zacks. The firm earned “Outperform” rating on Monday, December 7 by Wells Fargo. As per Monday, December 12, the company rating was downgraded by Janney Capital. The rating was upgraded by Keefe Bruyette & Woods to “Outperform” on Monday, December 7. The firm earned “Buy” rating on Wednesday, August 12 by National Securities. The firm has “Buy” rating given on Wednesday, April 27 by Janney Capital. See Medley Capital Corp (NYSE:MCC) latest ratings:

Paradice Investment Management Llc decreased Cra Intl Inc (CRAI) stake by 31.65% reported in 2016Q4 SEC filing. Paradice Investment Management Llc sold 272,279 shares as Cra Intl Inc (CRAI)’s stock declined 10.22%. The Paradice Investment Management Llc holds 588,081 shares with $21.52M value, down from 860,360 last quarter. Cra Intl Inc now has $303.52M valuation. The stock declined 2.02% or $0.72 reaching $34.97 per share. About 7,434 shares traded. CRA International, Inc. (NASDAQ:CRAI) has risen 49.42% since June 20, 2016 and is uptrending. It has outperformed by 32.72% the S&P500.

Paradice Investment Management Llc increased Sothebys (NYSE:BID) stake by 144,764 shares to 897,348 valued at $35.77M in 2016Q4. It also upped Eros Intl Plc (NYSE:EROS) stake by 506,907 shares and now owns 3.24M shares. Chemtura Corp (NYSE:CHMT) was raised too.

Since February 16, 2017, it had 0 insider purchases, and 1 sale for $76,000 activity. $76,000 worth of CRA International, Inc. (NASDAQ:CRAI) shares were sold by Lowenstein Arnold J.

Investors sentiment increased to 1.38 in Q4 2016. Its up 0.33, from 1.05 in 2016Q3. It increased, as 3 investors sold CRAI shares while 36 reduced holdings. 22 funds opened positions while 32 raised stakes. 6.85 million shares or 1.61% more from 6.74 million shares in 2016Q3 were reported. Goldman Sachs Grp holds 0% or 20,606 shares. Bankshares Of America De invested in 0% or 1,126 shares. Blackrock Inv Management Lc holds 36,888 shares or 0% of its portfolio. Eam Investors Ltd Liability Company holds 0.25% of its portfolio in CRA International, Inc. (NASDAQ:CRAI) for 52,119 shares. Brandywine Limited Liability Corp holds 4,770 shares. Paradice Invest Mgmt Limited Liability Co accumulated 588,081 shares. Sterling Cap Management Limited Co holds 0.01% or 21,502 shares. Rhumbline Advisers reported 11,275 shares. Numeric Invsts Lc holds 0.05% or 119,385 shares in its portfolio. Ariel Invs Limited Co owns 172,200 shares for 0.07% of their portfolio. Walleye Trading Limited Liability Company reported 1,500 shares. Nationwide Fund Advsrs, Pennsylvania-based fund reported 44,402 shares. Hillsdale Investment stated it has 0.26% in CRA International, Inc. (NASDAQ:CRAI). Brown Brothers Harriman Com has invested 0% of its portfolio in CRA International, Inc. (NASDAQ:CRAI). Citadel has 5,783 shares.

Medley Capital Corporation is a non-diversified closed-end management investment company. The company has market cap of $345.37 million. The Company’s investment objective is to generate current income and capital appreciation by lending directly to privately-held middle market companies, primarily through directly originated transactions to help these companies expand their business, refinance and make acquisitions. It has a 71.87 P/E ratio. The Company’s investment portfolio includes senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: